Showing results (131-140 of 335) with videos related to
Sort By:
Pageof 34
Cancer Genetics|February 16, 2015
Hypermethylation of the CpG dinucleotide in epidermal growth factor receptor codon 790: implications for a mutational hotspot leading to the T790M mutation in non-small-cell lung cancerAkiko Fujii, Taishi Harada, Eiji Iwama, et al.Plos One|August 14, 2008
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesAnna Kanerva, Sergio Lavilla-Alonso, Mari Raki, et al.Medical Oncology (Northwood, London, England)|April 30, 2018
Predictive factors for the development of irinotecan-related cholinergic syndrome using ordered logistic regression analysisYuko Kanbayashi, Takeshi Ishikawa, Motohiro Kanazawa, et al.Cancer Chemotherapy and Pharmacology|October 27, 2014
Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expressionHeyan Li, Koichi Takayama, Shuo Wang, et al.Cancer Chemotherapy and Pharmacology|January 6, 2006
A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trialMasao Ichiki, Masayuki Kawasaki, Koichi Takayama, et al.Chemotherapy|September 10, 2002
Phase I study of weekly irinotecan combined with weekly cisplatin in patients with advanced solid tumorsYoichi Nakanishi, Koichi Takayama, Hiroshi Wataya, et al.BMC Pharmacology & Toxicology|January 16, 2019
Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimensNaohisa Yoshida, Tetsuya Taguchi, Masayoshi Nakanishi, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|October 8, 2020
TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment SelectionAya Miyagawa-Hayashino, Satoru Okada, Naoko Takeda-Miyata, et al.Respirology Case Reports|August 24, 2023
Endobronchial metastasis of hepatocellular carcinoma treated with Lenvatinib: A case reportShota Takei, Akihiro Yoshimura, Chie Yamamoto, et al.International Journal of Oncology|March 4, 2020
Histone deacetylase inhibitor OBP‑801 and amrubicin synergistically inhibit the growth of squamous cell lung carcinoma by inducing mitochondrial ASK1‑dependent apoptosisYusuke Chihara, Yosuke Iizumi, Mano Horinaka, et al.Pageof 34